130 related articles for article (PubMed ID: 20570176)
1. Long-term outcomes of low-dose catheter-directed thrombolytic therapy: a 5-year single-center experience.
Sebastian AJ; Robinson GJ; Dyet JF; Ettles DF
J Vasc Interv Radiol; 2010 Jul; 21(7):1004-10. PubMed ID: 20570176
[TBL] [Abstract][Full Text] [Related]
2. Pulse-spray catheter directed thrombolysis in patients with recent onset or deterioration of lower extremity ischemia.
Chen YX; Liu CW; Zeng R; Li YJ; Ye W; Shao J
Chin Med J (Engl); 2012 Jan; 125(2):188-92. PubMed ID: 22340543
[TBL] [Abstract][Full Text] [Related]
3. Intraarterial recombinant tissue plasminogen activator thrombolysis of acute and semiacute lower limb arterial occlusion: quality assurance, complication management, and 12-month follow-up reinterventions.
Kühn JP; Hoene A; Miertsch M; Traeger T; Langner S; Hosten N; Puls R
AJR Am J Roentgenol; 2011 May; 196(5):1189-93. PubMed ID: 21512091
[TBL] [Abstract][Full Text] [Related]
4. Axillary catheter with intermittent boluses of local anaesthetic for ischaemic upper limb pain 18 h after failed rtPA thrombolysis.
Schulz-Stübner S; Martin C
Eur J Anaesthesiol; 2007 Aug; 24(8):722-4. PubMed ID: 17326852
[No Abstract] [Full Text] [Related]
5. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of accelerated catheter-directed thrombolysis in patients with acute arterial thrombosis.
Lukasiewicz A; Lichota W; Thews M
Vasc Med; 2016 Oct; 21(5):453-458. PubMed ID: 26994007
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
[TBL] [Abstract][Full Text] [Related]
8. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
9. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.
Comerota AJ; Weaver FA; Hosking JD; Froehlich J; Folander H; Sussman B; Rosenfield K
Am J Surg; 1996 Aug; 172(2):105-12. PubMed ID: 8795509
[TBL] [Abstract][Full Text] [Related]
10. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study.
De Santis A; Moscatelli R; Catalano C; Iannetti A; Gigliotti F; Cristofari F; Trapani S; Attili AF
Dig Liver Dis; 2010 Jun; 42(6):451-5. PubMed ID: 19819770
[TBL] [Abstract][Full Text] [Related]
11. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience.
Bratincsák A; Moore JW; El-Said HG
Catheter Cardiovasc Interv; 2013 Nov; 82(5):782-5. PubMed ID: 22718305
[TBL] [Abstract][Full Text] [Related]
12. The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation.
Boone JD; Sherwani SS; Herborn JC; Patel KM; De Wolf AM
Anesth Analg; 2011 Feb; 112(2):319-21. PubMed ID: 21127275
[TBL] [Abstract][Full Text] [Related]
13. [Catheter-directed thrombolysis of iliofemoral venous thrombosis].
Ly B; Njaastad AM; Sandbaek G; Solstrand R; Rosales A; Slagsvold CE
Tidsskr Nor Laegeforen; 2004 Feb; 124(4):478-80. PubMed ID: 14983192
[TBL] [Abstract][Full Text] [Related]
14. Catheter-directed thrombolysis in a patient with purpura fulminans.
Jones RG; Gardner GP; Morris ME
Am Surg; 2012 Nov; 78(11):E448-9. PubMed ID: 23089413
[No Abstract] [Full Text] [Related]
15. Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy.
Thenappan T; Anderson AS; Jeevanadham V; Rich JD; Shah AP
Circ Heart Fail; 2013 May; 6(3):e27-9. PubMed ID: 23694774
[No Abstract] [Full Text] [Related]
16. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device.
Delgado R; Frazier OH; Myers TJ; Gregoric ID; Robertson K; Shah NA; Kar B
J Heart Lung Transplant; 2005 Feb; 24(2):231-3. PubMed ID: 15701444
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
[TBL] [Abstract][Full Text] [Related]
18. [Local catheter thrombolysis].
Fischer M
Med Klin (Munich); 1993 Aug; 88(8):485-91. PubMed ID: 8413051
[No Abstract] [Full Text] [Related]
19. Subacute lower extremity arterial thrombosis; early outcomes of catheter directed thrombolysis with alteplase and importance of malnutrition assessed by CONUT score.
Sarı M; Çakmak EÖ; Karagöz A; Yılmaz F; Aytürk M; Fidan S; Alizade E; Arslantaş U; Tokgöz HC; Güner ZE; Alıcı G; Özkan B; Pala S
Turk Kardiyol Dern Ars; 2021 Oct; 49(7):568-578. PubMed ID: 34623300
[TBL] [Abstract][Full Text] [Related]
20. Catheter-Directed Low-Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter.
Orgeron GM; Pollard JL; Pourmalek P; Sloane PJ
Pharmacotherapy; 2015 Oct; 35(10):e153-8. PubMed ID: 26497485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
